Purpose Pharmacokinetic considerations in patients who have undergone Roux-en-Y gastric bypass (RYGB) are explored. Summary The prevalence of obesity, especially morbid obesity, has dramatically ...
For patients with diabetes undergoing Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), overall expenditures ...
Roux-en-Y gastric bypass (RYGBP ... The RYGBP procedure consisted of creating a stomach pouch and bypassing it to the jejunum to establish gastrointestinal continuity as described previously ...
The entire duodenum and a small portion of the proximal jejunum are bypassed ... or altered mesenteric blood flow. a RYGB = Roux-en-Y gastric bypass, Mct1 = monocarboxylic acid transporter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback